KIF18B and central nervous system cancer: Our results demonstrate for the first time the key role of KIF18B in the process of glioma canceration, thus proving that it is highly likely to be used as a potential therapeutic target for the treatment of glioma, igniting new hopes for improving the survival and prognosis of patients with glioma.